SMARCA4 and non-small cell lung carcinoma: SMARCA4, one of two SWI/SNF ATPase subunits, was first identified as a potential tumor suppressor in NSCLC, where expression is lost in 15%–50% of all tumors (Fukuoka et al., 2004; Reisman et al., 2003).